A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients With Cancer

BACKGROUND: Systemic inflammation and insulin resistance (IR) are closely related in patients with cancer. However, there is no relevant indicator that combines inflammation and IR to predict patient prognosis. Therefore, this study aimed to develop and validate a novel inflammation- and IR-related...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Guo-Tian, Xie, Hai-Lun, Zhang, He-Yang, Liu, Chen-An, Ge, Yi-Zhong, Zhang, Qi, Wang, Zi-Wen, Zhang, Xi, Tang, Meng, Song, Meng-Meng, Zhang, Xiao-Wei, Yang, Ming, Chen, Yong-Bing, Yu, Kai-Ying, Deng, Li, Gong, Yi-Zhen, Hu, Wen, Wang, Kun-Hua, Cong, Ming-Hua, Shi, Han-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252441/
https://www.ncbi.nlm.nih.gov/pubmed/35795140
http://dx.doi.org/10.3389/fendo.2022.905266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252441/
https://www.ncbi.nlm.nih.gov/pubmed/35795140
http://dx.doi.org/10.3389/fendo.2022.905266

Ejemplares similares